BOSTON—“We don’t have big data, but gazillions of pods of little data,” said Marcia Kean, Feinstein Kean Healthcare, at Strata Rx 2013 on Sept. 26. However, data liquidity—or the rapid, seamless and secure exchange of useful, standards-based information among authorized individuals and institutional senders—is poised to significantly advance biomedical research, she said.